학술논문
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial
Document Type
Article
Author
Source
In: ESMO Open . (ESMO Open, May 2024, 9(5))
Subject
Language
English
ISSN
20597029